ESMO 2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

ESMO 2024
Nov 12, 2024, 22:58 | Blog
Webinar on Lung Cancer Highlights from ESMO 2024 - SPCC
SPCC (Sharing Progress in Cancer Care) posted the following on LinkedIn: “Our webinar on Lung…
Nov 12, 2024, 18:55 | Insight
Jayant Gadrey: Analysis of ongoing clinical trials of ADCs for patients with breast cancer brain metastases
Jayant Gadrey, Resident Physician at the Tufts Medical Center, shared a post on X by…
Nov 7, 2024, 15:54 | Blog
ESMO 2024 GU Highlights hosted by Wenxin (Vincent) Xu - Dana-Farber Lank Center for Genitourinary Oncology
Dana-Farber Lank Center for Genitourinary Oncology shared a post on X: "Did you miss ESMO…
Nov 7, 2024, 00:11 | Blog
Chandler Park's Insights on the SunRISe Program and the Potential of TAR-200 for High-Risk Bladder Cancer
Chandler Park, Kentucky Physician Representative at ASCO State Executive Council, shared a post by Topline Bio on…
Nov 1, 2024, 14:29 | Blog
Manchester Cancer Research Centre's highlights from ESMO Congress 24
Manchester Cancer Research Centre shared a post on X: "ICYMI from 13th- 17th Sept, MCRC reps…
Oct 31, 2024, 17:06 | Blog
Sarah Louden: The latest insights and breakthroughs from the ESMO USA East meeting
Sarah Louden, Founder and CEO at Total Health Oncology, shared on LinkedIn: ''ESMO USA East…
Oct 23, 2024, 05:05 | Insight
Join SPCC’s live session for updates on the early and advanced lung cancer treatments presented at ESMO2024
SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn: “Did you miss the…
Oct 13, 2024, 18:44 | Blog
Registration open for the UTSW Simmons Cancer Center's 2024 Oncology Year in Review
UTSW Simmons Cancer Center shared a post on X: "Register now for our 2024 Oncology…
Oct 10, 2024, 12:54 | Dialogues
ESMO 2024 Highlights: OncoDaily Updates with Chandler Park on Cancer Breakthroughs
In episode three of OncoDaily, host Chandler Park welcomes Dr. Petros Grivas, a global leader…
Oct 9, 2024, 07:28 | Blog
New findings on the Decipher genomic classifier - Prostate Cancer Foundation
Prostate Cancer Foundation shared a post on X: ''The Decipher genomic classifier is well-established in…
Oct 6, 2024, 17:35 | Blog
Sarah Sammons: Demographics of patients with hepatoxicity from ribociclib
Sarah Sammons, Breast Medical Oncologist at Dana-Farber’s Breast Oncology Center, shared on X:  "Nice data…
Oct 5, 2024, 23:32 | Insight
AstraZeneca Revealed Positive Results for Muscle Invasive Bladder Cancer Patients at ESMO 2024
IMFINZI (durvalumab) perioperative regimen reduced the risk of recurrence by 32% and the risk of…
Oct 2, 2024, 23:57 | Blog
Nermean Mostafa: Great pleasure to participate in RTD Side Event during ESMO 2024
Nermean Mostafa, Head of Clinical Oncology unit at Ain shams University, posted the following on LinkedIn:…
Sep 30, 2024, 16:12 | Blog
Triparna Sen: Honored to participate in the Lung Cancer America patient advocacy workshop
Triparna Sen, Associate Professor, Icahn School of Medicine at Mount Sinai, shared a post on X:…
Sep 27, 2024, 16:34 | Blog
Explore groundbreaking cancer research at ESMO 2024
ESMO - European Society for Medical Oncology shared on LinkedIn: “Explore the latest cutting-edge scientific…
Sep 27, 2024, 15:09 | Blog
Oncogene-addicted NSCLC highlights from WCLC24 and ESMO24 - Lung Connect
Herbert Loong shared a post by LUNG CONNECT on LinkedIn, adding: "Thanks LUNG CONNECT for providing me w/…
Sep 25, 2024, 15:58 | Blog
ESMO 2024: Precision Oncology and the Future of Molecular Prevention - MediaMedic
MediaMedic shared a post on LinkedIn about MediaMedic article, adding: "ESMO 2024: Precision Oncology and…
Sep 24, 2024, 16:52 | Insight
ESMO: Combination therapy reduced agitated delirium in patients with advanced cancers study led by MD Anderson Cancer Center
Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common…
Sep 23, 2024, 14:15 | Blog
Silvia Marchesi: Erythrocytosis in thyroid cancer patients undergoing oral treatment
Silvia Marchesi, Oncology resident at National Institute of Cancer, shared on X: '' Excited to have…
Sep 23, 2024, 14:12 | Blog
Rasha Aboelhassan: Future plans for HER2-positive breast cancer patients
Rasha Aboelhassan shared on Linkedin: ''One of the best things we get from discussing experts…
Sep 23, 2024, 13:38 | Blog
Olubukola Ayodele: Addressing the mechanism of Endocrine Resistance in HR+ metastatic breast cancer patients at ESMO 2024
Olubukola Ayodele shared on Linkedin: "I'm thrilled to share that my friend Abeid M. Athman…
Sep 23, 2024, 12:10 | Insight
Luigi Lorini: Coming back from ESMO 2024 with many thoughts in my mind
Luigi Lorini shared on LinkedIn: "Coming back from ESMO 2024 with many thoughts in my…
Sep 23, 2024, 11:36 | Blog
OncoDaily Party Barcelona
On September 13, 2024, OncoDaily Party took place at the Chiringuito Mokai Beach Bar in…
Sep 21, 2024, 10:25 | Blog
Chris Cronin: First session of my ESMO24 is gonna be hard to top
Chris Cronin, Specialist Registar Medical Oncology, Beaumont Hospital Dublin, shared a post on X: "First…
Sep 19, 2024, 11:07 | Blog
Elias Ortega Chahla: ESMO - YO Mentorship Session
Elias Ortega Chahla, Medical Director (Hematology/Oncology), IQVIA, shared a post on LinkedIn: "ESMO - YO…
Sep 19, 2024, 09:02 | Blog
Noemi Reguart: Lenvatinib plus pembro in pretreated B3-thymoma and thymic carcinoma by Jordi Remon
Noemi Reguart shared a post on X: "ESMO 2024 - Jordi Remon elegantly presenting PECATI phase…
Sep 19, 2024, 08:59 | Insight
Fantastic talk by Toni Choueiri at ESMO2024 on Ti-Nivo2 trial
Petros Grivas shared a post by Yüksel Ürün on X, adding: "Fantastic talk by brilliant Toni Choueiri…
Sep 18, 2024, 14:24 | Blog
Paolo Tarantino: ESMO’s environmental commitment
Paolo Tarantino shared a post on X: "Inspiring to see The European Society for Medical Oncology…
Sep 18, 2024, 14:20 | Blog
Amol Akhade: What's the story for Day 2 of ESMO2024
Amol Akhade shared a post on X: "So what's the story for day 2 of ESMO24…
Sep 17, 2024, 21:57 | Opinion
Emir Sokolović on the impact of social media interventions in healthcare
Emir Sokolović, Medical Oncology Resident at Clinical center University of Sarajevo, shared on LinkedIn: "An…
Sep 17, 2024, 19:54 | Insight
Rasha Aboelhassan: Great statement in ESMO24
Rasha Aboelhassan shared on LinkedIn: “Patricia Mucci Lorusso. Great statement in ESMO24. Improve patient care…
Sep 17, 2024, 15:18 | Blog
Arevik Stepanyan: National Center of Oncology of Armenia team is at ESMO 2024
Arevik Stepanyan, Head of the Cancer Registry Department at the National Center of Oncology in Armenia,…
Sep 17, 2024, 10:06 | Insight
Sumanta K. Pal: Important analysis of SWOG 1500 published just ahead of ESMO24
Sumanta K. Pal shared a post on X: "Huge congrats to Pedro C Barata, who drove…
Sep 17, 2024, 00:58 | Blog
David Dellamonica: Focus on tangible actions to redefine cancer care ahead of ESMO 2024
David Dellamonica shared a post by Greg Rossi, Senior Vice President of Oncology Europe and Canada…
Sep 16, 2024, 15:00 | Insight
Insights from ESMO24 Day 3
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Sep 15, 2024, 15:20 | Insight
Novel ADC AZD8205 demonstrates manageable safety profile and preliminary efficacy in first-in-human trial
The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar…
Sep 15, 2024, 15:01 | Insight
MD Anderson Research Highlights Special Edition: ESMO 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent…
Sep 14, 2024, 17:15 | Societies
45 Posts not to miss from ESMO24 Day 1
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Sep 10, 2024, 05:08 | Blog
Tanja Obradovic: Two practice-changing trials of Keytruda within Presidential Symposium of ESMO24
Tanja Obradovic shared on LinkedIn: "ESMO 2024 will have two practice-changing trials of Keytruda (Pembrolizumab)…
Aug 31, 2024, 18:14 | Blog
Raffaele Giusti: Time Toxicity of Cancer Treatment - Discussion at ESMO 2024
Raffaele Giusti, Medical director at Azienda Ospedaliera Sant'Andrea, shared a post on LinkedIn: "Time Toxicity…
Aug 26, 2024, 21:42 | Blog
Tanja Obradovic: Interesting update at ESMO 2024 on cancer-induced cachexia as PhII trial of ponsegromab
Tanja Obradovic posted on LinkedIn: “Interesting update will come at ESMO 2024 on possible option…
Aug 15, 2024, 16:57 | Blog
Shushan Hovsepyan: Must-Attend Educational Sessions at ESMO 2024
Shushan Hovsepyan shared on LinkedIn: "Must-Attend Educational Sessions at ESMO 2024. Get ready for ESMO…
Aug 1, 2024, 16:17 | Blog
Gevorg Tamamyan: OncoDaily Party Barcelona during the ESMO 2024
Gevorg Tamamyan shared a post on LinkedIn: "Who is coming to ESMO 2024? OncoDaily Party…
Aug 1, 2024, 09:36 | Insight
List of sessions not to be missed in sarcoma at ESMO 2024 by Shushan Hovsepyan
Shushan Hovsepyan shared on LinkedIn: "The ESMO 2024 author's list is now available and this is…
Jul 30, 2024, 02:16 | Blog
Myriam Chalabi: Abstract titles for ESMO24 are now online!
Myriam Chalabi shared on X: ”Abstract titles for ESMO24 now online! Full NICHE-3 cohort (59…
Jul 29, 2024, 09:41 | Blog
All titles and authors of regular abstracts are now online for ESMO 2024
ESMO - European Society for Medical Oncology shared on LinkedIn: "ESMO 24: All titles and…
Jul 24, 2024, 01:00 | Blog
Yige Bao: Our data from the high-risk UTUC nephron-sparing trial has been accepted at ESMO 2024
Yige Bao, Oncological Urologist and Microbiome researcher in West China Hospital, shared a post on X:…
Jul 13, 2024, 13:27 | Blog
Jehad Yasin: Two of our abstracts have been accepted for presentation at ESMO Congress 2024
Jehad Yasin, Member of the American Physician Scientists Association (APSA) and ESMO, shared a post…
May 18, 2024, 08:38 | Opinion
New Insights to Tackle Sexual Impairment in BC - ESMO
The European Society for Medical Oncology (ESMO) shared on X: “ESMO Breast 24: Two studies on…
May 18, 2024, 08:31 | Opinion
Guillermo Villacampa: Marleen Kok presents the ESMO Breast 24 key message in translation research
Paolo Tarantino shared the following post by Guillermo Villacampa, Biostatistician in the Oncology Data Science…
All: 50 Posts: 1 - 100
Special Coverage